|
Volumn 392, Issue 6674, 1998, Pages 315-
|
Perils in free market genomics
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FINANCIAL MANAGEMENT;
GENOME;
NOTE;
PRIORITY JOURNAL;
SCIENCE;
TECHNOLOGY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETIC RESEARCH;
GENETICS AND REPRODUCTION;
REGULATION;
RISKS AND BENEFITS;
BIOETHICS;
GENE THERAPY;
GENETIC ENGINEERING;
GENETIC ENHANCEMENT;
GENETIC RESEARCH;
GENOME, HUMAN;
GERM CELLS;
HEALTH POLICY;
HUMANS;
MARKETING OF HEALTH SERVICES;
RISK ASSESSMENT;
SOCIAL CONTROL, FORMAL;
|
EID: 34548004979
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/32717 Document Type: Note |
Times cited : (2)
|
References (0)
|